The World Health Organization has introduced a comprehensive program to supply free cancer medicines to thousands of children every year. Focused on low- and middle-income countries, the initiative seeks to bridge the treatment gap, ensuring that young patients receive timely and effective care regardless of financial barriers.
The program will target high-priority childhood cancers, including leukemia and lymphoma, which account for a large percentage of pediatric cases globally. By improving access to essential medicines, WHO aims to reduce childhood cancer mortality rates and strengthen healthcare systems in underserved regions.
This initiative highlights the organization’s commitment to equitable healthcare, ensuring that lifesaving treatments reach the most vulnerable populations. It also includes training for medical staff, supply chain support, and partnerships with governments to create sustainable pediatric oncology programs worldwide.
WHO, cancer medicines, pediatric healthcare
